Early treatment of HER2-amplified brain tumors with targeted NK-92 cells and focused ultrasound improves survival

BACKGROUND: Malignant brain tumors have a dismal prognosis, with residual tumor remaining after surgery necessitating adjuvant chemoradiotherapy. The blood-brain barrier hinders many chemotherapeutic agents, resulting in modest treatment efficacy. We previously demonstrated that targeted natural kil...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Alkins, Ryan, Burgess, Alison, Kerbel, Robert, Wels, Winfried S., Hynynen, Kullervo
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Basic and Translational Investigations
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896543/
https://ncbi.nlm.nih.gov/pubmed/26819443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov318
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki